Cephalon Launches Provigil Label Expansion; DTC Campaign Possible
Executive Summary
Cephalon is launching its expanded Provigil label with a focus on educating physicians on sleepiness
You may also be interested in...
Gabitril Potential In Anxiety Aided By Positive Side Effect Profile – Cephalon
Cephalon hopes to market the anti-epileptic Gabitril (tiagabine) for generalized anxiety disorder by 2006 based on a favorable side effect profile
Cephalon Provigil Has 28% Awareness Among Primary Care Physicians
Cephalon will step up its efforts to target primary care physicians in an effort to raise awareness about the sleep disorder agent Provigil (modafinil)
Gabitril Potential In Anxiety Aided By Positive Side Effect Profile – Cephalon
Cephalon hopes to market the anti-epileptic Gabitril (tiagabine) for generalized anxiety disorder by 2006 based on a favorable side effect profile